Skip to Content

With iPad 2, Apple Extends Its Lead

Relatively minor upgrades still leave the iPad out in front of rivals.
March 2, 2011

Just 11 months after the iPad created a new category of computer, the iPad 2 is here. It’s thinner, faster, and packs more battery power than its predecessor–or any competitor. It also packs two cameras for shooting video, photos, or for video conferencing.

The new model doesn’t bring any major new technology, though, which left more time in Steve Jobs’ presentation than usual for pointing out that competing tablets are still way off the pace.

He laughed at Samsung’s Galaxy Tab – reviewed here – that debuted last year: “A lot of these were probably on the shelf by the end of the year.” And he declared that the latest crop of tablets, mostly powered by Google’s tablet-ized version of Android, “haven’t even caught up with the first iPad.”

Jobs claimed that most iPad rivals are still thicker than the original iPad (9.3mm), while the iPad 2 is a third thinner (8.8mm). He pointed out that five of the six iPad 2 models are cheaper than the most credible competitor, the Motorola Xoom that is the the flagship for Google’s version of Android and costs $799. He sounded incredulous while explaining that just 16 apps have been designed for the tablet-ized version of Android, compared to 65,000 designed for the iPad.

It all adds up to news that offers more to industry analysts than tech-loving consumers. Sure, the iPad 2 feels lighter and a little more responsive when multitasking and it has cameras, but if you’ve used an iPad before you’ll notice little different. Tablet fans looking for some more exciting changes currently have to rest their hopes in far-from-solid rumors that iPad 3, supposedly out later this year, will feature major design and technology changes.

Keep Reading

Most Popular

This startup wants to copy you into an embryo for organ harvesting

With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.

VR is as good as psychedelics at helping people reach transcendence

On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.

This nanoparticle could be the key to a universal covid vaccine

Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.